New York Medical College's 155th Commencement Exercises Set for May 22
Renowned cardiologist and distinguished biomedical researcher, Elizabeth G. Nabel, M.D., will deliver the Commencement address
Jennifer Riekert, M.B.A.
Vice President of Communications
New York Medical College
(914) 594-4552
Jennifer_Riekert@nymc.edu
Elizabeth G. Nabel, M.D., will deliver the Commencement address to graduates of New York Medical College on May 22 at 5:00 p.m. in Carnegie Hall in New York City
VALHALLA, N.Y., May 15, 2014—Renowned cardiologist and distinguished biomedical researcher, Elizabeth G. Nabel, M.D., will deliver the Commencement address to graduates of New York Medical College (NYMC) on May 22 at 5:00 p.m. in Carnegie Hall in New York City. The College will award 198 doctor of medicine (M.D.) degrees, 22 doctor of physical therapy (D.P.T.) degrees, 7 doctor of philosophy (Ph.D.) degrees, 77 master of science (M.S.) degrees, 79 master of public health (M.P.H.) degrees and 5 doctor of public health (Dr.P.H.) degrees to the Class of 2014.
Dr. Nabel is president of Brigham and Women’s Hospital (BWH) and professor of medicine at Harvard Medical School. Her unique perspective on health care is based on her experience as a physician, research scientist, academic medicine leader and wellness advocate. At BWH, she led development of a comprehensive strategic plan that defines a new model of medicine and initiatives that include a new translational research and clinical facility and a $1 billion campaign to advance innovation, patient care and community health. As director of the National Heart, Lung, and Blood Institute (NHLBI) from 2005 to 2009, Dr. Nabel leveraged the $3 billion research portfolio to establish pioneering scientific programs in genomics, stem cells, and translational research. One of her signature advocacy efforts was the Red Dress Heart Truth campaign, which raises heart awareness in women through innovative partnerships.
An accomplished physician-scientist, Dr. Nabel’s work on the molecular genetics of cardiovascular diseases has produced 17 patents and more than 250 scientific publications. Her scientific contributions in cardiovascular gene transfer have developed molecular and cellular techniques, delineated that the pathophysiology of atherosclerosis and clarified the processes of cell division and growth of vascular smooth muscle cells in blood vessels. Her studies on Hutchinson-Gilford Progeria Syndrome have characterized the vascular smooth muscle cell defect leading to premature heart attack and stroke.